Strides Pharma Science Ltd Q3 FY2023 consolidated loss at Rs. 80.02 crores

The Board of Directors of Strides Pharma Science Limited, at its meeting held today have approved the financial results of the company for the period ended December 31, 2022 - Q3FY23 and 9MFY23.

Related Keywords

,Strides Pharma Science Ltd ,Strides Pharma Science ,Pharma Science Limited ,Strides Pharma Science Limited ,Stridespharmascience ,Q3fy23 ,9mfy23 ,Resultupdate ,